erythrosine has been researched along with Idiopathic Parkinson Disease in 11 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of paeonol on neuron cell model of Parkinson disease (PD)." | 7.81 | [Neuroprotective effects of paeonol in a cell model of Parkinson disease]. ( Geng, ZM; Hu, ZW; Wang, H; Wang, SY; Zhao, B, 2015) |
| "To investigate the effects of paeonol on neuron cell model of Parkinson disease (PD)." | 3.81 | [Neuroprotective effects of paeonol in a cell model of Parkinson disease]. ( Geng, ZM; Hu, ZW; Wang, H; Wang, SY; Zhao, B, 2015) |
| "Rotenone (1 μg) was unilaterally injected into the median forebrain bundle to induce the degeneration of the nigrostriatal pathway." | 1.51 | Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism. ( Abin-Carriquiry, JA; Costa, G; Dajas, F; Ferreira, M; Mouhape, C; Prunell, G, 2019) |
| "Prion diseases are associated with the misfolding of the host-encoded cellular prion protein (PrP(C)) into a disease associated form (PrP(Sc))." | 1.35 | Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence. ( Cappai, R; Coleman, BM; Han, S; Hatters, DM; Hill, AF; Nisbet, RM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hannestad, JK | 1 |
| Rocha, S | 1 |
| Agnarsson, B | 1 |
| Zhdanov, VP | 1 |
| Wittung-Stafshede, P | 1 |
| Höök, F | 1 |
| Flavin, WP | 1 |
| Bousset, L | 1 |
| Green, ZC | 1 |
| Chu, Y | 1 |
| Skarpathiotis, S | 1 |
| Chaney, MJ | 1 |
| Kordower, JH | 1 |
| Melki, R | 1 |
| Campbell, EM | 1 |
| Mouhape, C | 1 |
| Costa, G | 1 |
| Ferreira, M | 1 |
| Abin-Carriquiry, JA | 1 |
| Dajas, F | 1 |
| Prunell, G | 1 |
| van Diggelen, F | 1 |
| Hrle, D | 1 |
| Apetri, M | 1 |
| Christiansen, G | 1 |
| Rammes, G | 1 |
| Tepper, A | 1 |
| Otzen, DE | 1 |
| Wang, H | 1 |
| Geng, ZM | 1 |
| Hu, ZW | 1 |
| Wang, SY | 1 |
| Zhao, B | 1 |
| Stefanovic, AN | 1 |
| Lindhoud, S | 1 |
| Semerdzhiev, SA | 1 |
| Claessens, MM | 1 |
| Subramaniam, V | 1 |
| Coleman, BM | 1 |
| Nisbet, RM | 1 |
| Han, S | 1 |
| Cappai, R | 1 |
| Hatters, DM | 1 |
| Hill, AF | 1 |
| Yeh, HH | 1 |
| Yang, YH | 1 |
| Chen, SH | 1 |
| Janoshazi, A | 1 |
| Sellal, F | 1 |
| Marescaux, C | 1 |
| Danion, JM | 1 |
| Warter, JM | 1 |
| de Barry, J | 1 |
| Junn, E | 1 |
| Taniguchi, H | 1 |
| Jeong, BS | 1 |
| Zhao, X | 1 |
| Ichijo, H | 1 |
| Mouradian, MM | 1 |
| Bora, SS | 1 |
| Radichevich, I | 1 |
| Werner, SC | 1 |
1 trial available for erythrosine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Artifactual elevation of PBI from an iodinated dye used to stain medicinal capsules pink.
Topics: Bipolar Disorder; Blood Proteins; Capsules; Carbonates; Chromatography, Paper; Clinical Trials as To | 1969 |
10 other studies available for erythrosine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Single-vesicle imaging reveals lipid-selective and stepwise membrane disruption by monomeric α-synuclein.
Topics: alpha-Synuclein; Fluoresceins; Humans; Kinetics; Lipid Bilayers; Membrane Lipids; Membranes; Nerve T | 2020 |
Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins.
Topics: alpha-Synuclein; Amyloidogenic Proteins; Animals; Autophagy; Biological Transport; Brain; Cells, Cul | 2017 |
Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.
Topics: Analysis of Variance; Animals; Cell Count; Disease Models, Animal; Dopamine; Dopaminergic Neurons; D | 2019 |
Two conformationally distinct α-synuclein oligomers share common epitopes and the ability to impair long-term potentiation.
Topics: Aldehydes; alpha-Synuclein; Animals; Circular Dichroism; Docosahexaenoic Acids; Epitopes; Fatty Acid | 2019 |
[Neuroprotective effects of paeonol in a cell model of Parkinson disease].
Topics: 1-Methyl-4-phenylpyridinium; Acetophenones; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase | 2015 |
Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
Topics: alpha-Synuclein; Cell Membrane Permeability; Fluoresceins; Humans; Membranes, Artificial; Multiprote | 2015 |
Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence.
Topics: Alzheimer Disease; Animals; Cysteine; Fluoresceins; Fluorescence; Huntington Disease; Luminescent Me | 2009 |
Simultaneous determination of memantine and amantadine in human plasma as fluorescein derivatives by micellar electrokinetic chromatography with laser-induced fluorescence detection and its clinical application.
Topics: Acetonitriles; Alzheimer Disease; Amantadine; Antiparkinson Agents; Chemical Fractionation; Chromato | 2010 |
Alteration of protein kinase C conformation in red blood cells: a potential marker for Alzheimer's disease but not for Parkinson's disease.
Topics: Age Factors; Aged; Alzheimer Disease; Analysis of Variance; Biomarkers; Enzyme Inhibitors; Erythrocy | 2006 |
Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Blotting, Western; Carrier Proteins; Cell Nucleus; | 2005 |